Search filters

Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1  BRCA2 or PALB2 Mutation
18 years - 99 years
All genders
The purpose of this study is to compare the usual treatment alone to using one year of olaparib. We will enroll subject who have been diagnosed with pancreatic cancer and have undergone surgery to remove the cancer. Only patients who are found to have a BRCA1, BRCA2 or PALB2 mutation …
99 years or below
All genders
This is a prospective, observational study that will enroll 8000 patients with acute-onset ischemic stroke, intracerebral hemorrhage or aneurysmal subarchnoid hemorrhage within 6 weeks of onset. Participants will undergo both in person and telephone follow up in order to assess for longitudinal cognitive and functional outcomes.
 A Phase 3  Prospective  Multi-Center  Single-Arm  Open-Label Study to Evaluate VeraCept  a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy  Safety  and Tolerability
18 years - 45 years
Accepts healthy volunteer
Female
Phase 3
A research study for woman of child bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.
 A multicenter  double-blind  randomized  placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
18 years - 100 years
All genders
Phase 3
Interventional
The purpose of this study is to find out if the investigational drug, apraglutide and investigational drug , is able to reduce the volume per week of PS required in adults with short bowel syndrome and intestinal failure.
 To identify reliable markers of LRRK2 activity in human CSF.
30 years - 99 years
Accepts healthy volunteer
All genders
The purpose of this research study is to evaluate new tests for Parkinson's disease (PD) that may help in developing better treatments.
 Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device
18 years - 99 years
All genders
Interventional
The research study is being conducted to determine the safety and effectiveness of an investigational device, called the Edwards EVOQUE Replacement system (EVOQUE system) with Optimal Medical Therapy (OMT) compared to OMT alone for the treatment of tricuspid valve regurgitation (TR)
 Cooling to Help Injured lungs (CHILL) for  Therapeutic Hypothermia in Patients with ARDS (acute respiratory distress syndrome )
18 years - 65 years
All genders
Phase 2
This study will analyze the potential lung protective effect of mild therapeutic hypothermia (TH), similar to that used for cardiac arrest, in ICU patients with acute respiratory distress syndrome (ARDS).
 Study: A Randomized Double Blind Phase II Study of Dabrafenib and Trametinib With or Without Hydroxychloroquine in Advanced BRAF V600E/K Melanoma With Elevated LDH
18 years - 80 years
All genders
This phase II trial investigates how well adding hydroxychloroquine to the standard treatment of dabrafenib and trametinib works to overcome resistance and delay disease progression in treating patients with stage IIIC or IV BRAF V600E/K melanoma. Giving hydroxychloroquine together with dabrafenib and trametinib may work better than dabrafenib and trametinib …
 A  STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE-ONSET POMPE DISEASE
18 years - 99 years
All genders
Phase 3
Interventional
A STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE-ONSET POMPE DISEASE
 A Randomized Study to Compare Efficacy  Safety  and Tolerability of Macitentan 75mg Versus Macitentan 10mg in Patients with Pulmonary Arterial Hypertension  Followed by an Open-label Treatment Period with Macitentan 75mg
18 years - 75 years
All genders
Phase 3
TThe research study is being conducted to compare macitentan 75 mg with the approved macitentan 10 mg to see if it is well tolerated, safe and useful for treating patients with pulmonary arterial hypertension (PAH).
351 - 360 of 1202